Related Experiment Video

Updated: Sep 27, 2026

Fingerprinting Cardiolipin in Leukocytes by Mass Spectrometry for a Rapid Diagnosis of Barth Syndrome
06:48

Fingerprinting Cardiolipin in Leukocytes by Mass Spectrometry for a Rapid Diagnosis of Barth Syndrome

Published on: March 23, 2022

A case of Wilson-Mikity syndrome with high serum KL-6 levels

Takeshi Takami1, Atsushi Kumada, Yukito Takei

  • 1Department of Pediatrics, Tokyo Medical University, 6-7-1 Nishishinjuku, Shinjuku-ku, Japan.

Journal of Perinatology : Official Journal of the California Perinatal Association
|January 31, 2003
PubMed

Insights

In infants with Wilson-Mikity syndrome, serum KL-6 levels closely mirrored disease activity. This finding suggests KL-6 is a valuable biomarker for interstitial lung disease in this pediatric condition.

Area of Science:

  • Pediatric Pulmonology
  • Biomarker Discovery
  • Interstitial Lung Diseases

Background:

  • Elevated serum KL-6 and surfactant protein D (SP-D) are observed in adult interstitial pneumonia.
  • Wilson-Mikity syndrome is a rare, severe form of neonatal chronic lung disease.

Observation:

  • This case study monitored serum KL-6, SP-D, and lactate dehydrogenase (LDH) in an infant diagnosed with Wilson-Mikity syndrome.
  • The infant's clinical symptoms were tracked alongside these biomarker levels.

Findings:

  • Serum KL-6 levels demonstrated a stronger correlation with the infant's clinical symptoms compared to SP-D and LDH.
  • High serum KL-6 concentrations appeared to reflect active interstitial lung disease in Wilson-Mikity syndrome.

Implications:

  • Serum KL-6 may serve as a sensitive indicator of disease activity in pediatric interstitial lung diseases like Wilson-Mikity syndrome.
  • Further research could validate KL-6 as a non-invasive biomarker for monitoring treatment response and disease progression in infants.

Related Concept Videos

Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Disorders of Leukocytes01:27

Disorders of Leukocytes

Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...